Bright Minds Biosciences Financial Overview
Bright Minds Biosciences's market cap is currently C$899.72M. The company's EPS TTM is C$-0.775; its P/E ratio is -67.14; Bright Minds Biosciences is scheduled to report earnings on December 24, 2025, and the estimated EPS forecast is C$-1.22. See an overview of income statement, balance sheet, and cash flow financials.
